Parexel is among the world's largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. With over 24,000 global professionals, including a team of more than 3,000 safety professionals, 250 safety physicians and 350+ medical writers, Parexel partners with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind. Our team has worked on more than 3,000 pharmacovigilance projects in the past five years alone across more than 5,000 products, encompassing a multitude of therapeutic areas. Our innovation ecosystem enhances clinical trial efficiency at every phase, with technology-enabled processes and global insight that streamline drug development journeys. Parexel’s 40-year industry experience and strong track record drive healthcare innovation in complex areas.
With the people, insight and focus on operational excellence, we Work With Heart every day to treat patients with dignity and continuously learn from their experiences. Parexel increases access to clinical research, making it a care option for anyone, anywhere. Our focus on operational excellence, combined with deep industry knowledge, moves the industry forward, ensuring every trial makes a difference. For more information, visit parexel.com and follow us on LinkedIn, X, Facebook and Instagram.